Navigation Links
Boston MedTech Advisors Enters Into 50th Engagement with Israeli Life Sciences Companies
Date:12/5/2013

DEDHAM, Mass., Dec. 5, 2013 /PRNewswire-iReach/ -- Boston MedTech Advisors, Inc. (BMTA), a consulting company that supports companies bringing medical technologies to market, announced today that it has entered into an agreement with its 50th Israeli client. Headquartered in Dedham and with offices in Israel and Germany, BMTA provides its clients with expertise in regulatory affairs, clinical development, reimbursement, market strategy and commercialization of innovative technologies. BMTA's clients include early and growth stage companies, those with established revenues and growing market presence. Israeli companies represent over a third of BMTA's activities.

BMTA has been active in the Israeli market since its founding 10 years ago. Many of the Israeli companies started working with BMTA early in their development and continue to collaborate with BMTA as they commercialize their technologies. "Our long-term presence in the U.S. market, our focus on establishing clinical adoption for innovative technologies in the rapidly changing U.S. and world markets, and our ability to interact with Israeli companies and investors position us in a unique place in the vibrant Israeli market," stated David Barone, a principal of BMTA and a strong promoter of expanding business relationships between Massachusetts and Israel, "Massachusetts has much to offer to Israeli life science companies and those taking advantage of the available resources often find that local relationships provide significant value."

Through their collaboration with BMTA, a number of Israeli companies have selected Massachusetts as their base of operation in the U.S. Other companies conducted clinical research in Massachusetts-based hospitals, or have established advisory, scientific or business collaborations with local leading experts. Zvi Ladin, a principal of BMTA, said at a recent meeting: "We constantly seek to expand the value we offer to our portfolio companies. We have expanded our services to include planning and management of clinical studies, which are tightly integrated with other services. Among our activities on behalf of Israeli companies we manage clinical research activities, which have led to regulatory clearances for new technologies that are now serving thousands of patients on a daily basis. We are in a unique position to help Israeli companies to advance from concept to sales, and in the process, help mentor Israeli companies and their boards, bridging language and culture gaps by leveraging the Israeli background of some of our BMTA team members."

"I have been involved through three different Israel-based medtech companies with BMTA, being supported in the development of market strategy, regulatory, reimbursement and other critical elements of our plans to commercialize our new medical technologies. BMTA experience, ability to identify the barriers and support the spectrum of activities that eventually lead to market acceptance, and their ability to effectively work with Israeli companies, is unique", stated Israel Schreiber, CEO of Ornim Medical, and past CEO of ITGI Medical (TASE:ITGI) and Itamar Medical (TASE:Itamar). "Our collaboration with BMTA was among the reasons we set the U.S. headquarters for Itamar Medical in Massachusetts, and will consider doing the same with Ornim Medical," added Schreiber.

BMTA's collaboration with Israeli companies is further enhanced by other activities that expand collaboration between Massachusetts and Israel. Last month BMTA organized a seminar on recent changes in regulatory and reimbursement environment in the U.S. and their implications for medical device manufacturers. The seminar took place in Tel Aviv, Israel, and was attended by senior executives from 60 Israeli life science companies.

BMTA also played a key role in supporting and organizing the New England - Israel Business Council (NEIBC) Life Sciences Summits in 2010 and 2012, which brought together hundreds of Massachusetts-based leaders in science, industry, research and investment to interact with their Israeli counterparts, while discussing some of the most pertinent issues affecting the healthcare industry. NEIBC sponsors visits to Massachusetts by Israeli medical technology companies seeking local collaboration, and organizes events in Israel intended to present Massachusetts' extensive resources to the flourishing Israeli life science industry. David Barone, who also serves as the Chairman of the New England Israel- Business Council's Life Sciences Committee, said "it is very helpful to relate to specific examples of BMTA portfolio companies when discussing the advantages of Massachusetts for Israeli life science companies."

About Boston MedTech Advisors, Inc.

BMTA is a consulting and professional services firm supporting commercialization of new medical technologies and helping manufacturers achieve market adoption of new products, technologies and procedures. BMTA has offices in Dedham, MA, Germany and Israel. BMTA activities include market research, regulatory affairs, development of clinical evidence, assessment of reimbursement and economics of products and related procedures, marketing strategy and more. BMTA has consulted and assisted U.S. and offshore medical technology organizations, ranging from start-ups to Fortune 500 companies, as well as investors, tech transfer offices and healthcare providers. Additional information about Boston MedTech Advisors can be found on its web sites www.bmtadvisors.com and www.bmtCROgroup.com.

Media Contact: David Barone, Boston MedTech Advisors, 781.407.0900 x102, dbarone@bmtadvisors.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Boston MedTech Advisors
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Engineering Corporation awarded ISO 9001 and ISO 13485 certifications
2. Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific
3. Current Regulatory Expectations Affecting the Validation of Reusable Medical Devices is Subject of Dec. 4th Seminar in Boston
4. Boston Scientific Completes Acquisition Of Bard Electrophysiology
5. Boston Scientific To Participate In 2013 Credit Suisse Healthcare Conference
6. Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013
7. Smith Brothers Cough Drops Wants To Rename Boston "Beardston"
8. Boston Scientific Receives Prestigious 2013 Prix Galien Award For Best Medical Technology
9. Biocartis Presents the Successful use of Idylla[TM] for the Detection of the BRAF Mutation Status in Tumour Samples at the International AACR Congress (American Association for Cancer Research) in Boston
10. TVM Capital MENA Announces Affiliation with Bostons Spaulding Rehabilitation Network
11. Cancer Experts Meet in Boston to Discuss a Promising Approach to Treating the Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... Pekin, IL (PRWEB) , ... October 13, 2017 ... ... Foundation, which established the certification process to promote standards of excellence for the ... iaedp™ Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
Breaking Medicine News(10 mins):